A detailed history of Mutual Of America Capital Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 14,877 shares of MYGN stock, worth $423,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,877
Previous 15,253 2.47%
Holding current value
$423,548
Previous $325,000 11.69%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$17.98 - $25.47 $6,760 - $9,576
-376 Reduced 2.47%
14,877 $363,000
Q1 2024

May 02, 2024

SELL
$17.59 - $23.59 $4,678 - $6,274
-266 Reduced 1.71%
15,253 $325,000
Q4 2023

Jan 26, 2024

BUY
$13.91 - $21.32 $16,232 - $24,880
1,167 Added 8.13%
15,519 $297,000
Q3 2023

Nov 09, 2023

SELL
$15.99 - $23.22 $25,216 - $36,617
-1,577 Reduced 9.9%
14,352 $230,000
Q2 2023

Aug 11, 2023

SELL
$17.56 - $23.76 $13,310 - $18,010
-758 Reduced 4.54%
15,929 $369,000
Q1 2023

May 04, 2023

SELL
$15.26 - $23.75 $4,516 - $7,030
-296 Reduced 1.74%
16,687 $387,000
Q4 2022

Feb 10, 2023

BUY
$14.51 - $20.99 $13,639 - $19,730
940 Added 5.86%
16,983 $246,000
Q3 2022

Nov 08, 2022

BUY
$18.21 - $27.88 $46,417 - $71,066
2,549 Added 18.89%
16,043 $306,000
Q2 2022

Aug 10, 2022

BUY
$16.45 - $25.88 $32,686 - $51,423
1,987 Added 17.27%
13,494 $245,000
Q1 2022

May 02, 2022

BUY
$22.67 - $28.01 $13,533 - $16,721
597 Added 5.47%
11,507 $290,000
Q4 2021

Feb 03, 2022

BUY
$24.13 - $32.63 $12,089 - $16,347
501 Added 4.81%
10,910 $301,000
Q3 2021

Nov 10, 2021

SELL
$29.97 - $36.66 $16,333 - $19,979
-545 Reduced 4.98%
10,409 $336,000
Q2 2021

Aug 06, 2021

BUY
$25.39 - $32.61 $23,104 - $29,675
910 Added 9.06%
10,954 $335,000
Q1 2021

May 13, 2021

BUY
$19.92 - $31.6 $12,888 - $20,445
647 Added 6.89%
10,044 $306,000
Q4 2020

Feb 12, 2021

BUY
$12.16 - $19.77 $4,766 - $7,749
392 Added 4.35%
9,397 $186,000
Q3 2020

Nov 13, 2020

BUY
$11.25 - $14.75 $60,705 - $79,591
5,396 Added 149.52%
9,005 $117,000
Q2 2020

Aug 06, 2020

BUY
$10.69 - $16.49 $3,570 - $5,507
334 Added 10.2%
3,609 $41,000
Q1 2020

May 11, 2020

BUY
$9.78 - $29.53 $6,220 - $18,781
636 Added 24.1%
3,275 $47,000
Q4 2019

Feb 11, 2020

SELL
$20.93 - $35.1 $2,909 - $4,878
-139 Reduced 5.0%
2,639 $72,000
Q3 2019

Nov 14, 2019

BUY
$22.08 - $47.08 $3,356 - $7,156
152 Added 5.79%
2,778 $80,000
Q2 2019

Aug 12, 2019

BUY
$22.67 - $35.0 $11,992 - $18,515
529 Added 25.23%
2,626 $73,000
Q1 2019

May 13, 2019

BUY
$26.93 - $34.7 $7,351 - $9,473
273 Added 14.97%
2,097 $70,000
Q4 2018

Feb 12, 2019

BUY
$27.23 - $45.56 $12,934 - $21,641
475 Added 35.21%
1,824 $53,000
Q3 2018

Nov 13, 2018

BUY
$37.57 - $50.34 $41,026 - $54,971
1,092 Added 424.9%
1,349 $62,000
Q2 2018

Aug 09, 2018

BUY
$27.75 - $40.17 $7,131 - $10,323
257 New
257 $10,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.3B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.